Gareth Maglennon
AstraZeneca (South Korea)(KR)AstraZeneca (Singapore)(SG)AstraZeneca (Spain)(ES)
Publications by Year
Research Areas
PARP inhibition in cancer therapy, Estrogen and related hormone effects, Advanced Breast Cancer Therapies, Phytochemicals and Medicinal Plants, Toxin Mechanisms and Immunotoxins
Most-Cited Works
- → Preclinical Comparison of the Blood–brain barrier Permeability of Osimertinib with Other EGFR TKIs(2020)221 cited
- → Genomic signatures of human and animal disease in the zoonotic pathogen Streptococcus suis(2015)192 cited
- → Persistence of viral DNA in the epithelial basal layer suggests a model for papillomavirus latency following immune regression(2011)173 cited
- → Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and Trapper(2022)161 cited
- → Universal Sample Preparation Unlocking Multimodal Molecular Tissue Imaging(2020)113 cited
- → Immunosuppression Facilitates the Reactivation of Latent Papillomavirus Infections(2013)96 cited